Could the C-reactive protein/albumin Ratio Predict Mortality in Patients with Common Variable İmmunodeficiency?

Common variable immunodeficiency (CVID) is the most common symptomatic in adults. This study assessed utility of using C-reactive protein (CRP)/albumin ratio (CAR) at diagnosis to predict mortality CVID patients. Between 2010 and 2022, hospital records follow-up cards patients with were reviewed retrospectively. Seventy-five included study. CRP 0–5 mg/L albumin 3.5–5.5 g/dL taken as references. The CAR was obtained by dividing value value. Of patients, 41 (55%) male 34 (35%) female. median age 38 (21–77) years. rate during time 20%. 41% had splenomegaly, 10.6% malignancy, 39% bronchiectasis. cut-off >2.18 (sensitivity: 88.4%, specificity: 90.1%). When classified according CAR, patient group a > 2.18 statistically significantly higher than ≤ 2.18. cheap, simple, easily calculated parameter that can